• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:202401005861687950   Update date: Mar. 06, 2025

Tsutsumi Tsubasa

Tsutsumi Tsubasa
Research theme for competitive and other funds  (1):
  • 2024 - 2027 レジスタンス運動誘発マイオカインによる肝発がん抑制効果の機序
Papers (5):
  • Tsutsumi T, Kawaguchi T, Fujii H, Kamada Y, Takahashi H, Kawanaka M, Sumida Y, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Morishita A, Munekage K, Kawata K, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Tokushige A, Ueda S, Aishima S, Nakajima A, Okanoue T. Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan. Alimentary Pharmacology & Therapeutics. 2024. 59. 12. 1559-1570
  • Tsutsumi T, Nakano D, Kawaguchi M, Takahashi H, Kawaguchi T. Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 2024. 30. 2. 266-268
  • Tsutsumi T, Nakano D, Kawaguchi M, Hashida R, Yoshinaga S, Takahashi H, Anzai K & Kawaguchi T. MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men. Diabetology & Metabolic Syndrome. 2022. 14. 1. 115
  • Tsutsumi T, Eslam M, Kawaguchi T, Yamamura S, Kawaguchi A, Nakano D, Koseki M, Yoshinaga S, Takahashi H, Anzai K, George J, Torimura T. MAFLD Better Predicts the Progression of Atherosclerotic Cardiovascular Risk than NAFLD: Generalized Estimating Equation Approach. Hepatology Research. 2021. 51. 11. 1115-1128
  • Yamamura S. Kawaguchi T. Tsutsumi T. et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. liver international. 2020. 40. 12. 3018-3030
MISC (12):
  • 鈴木浩之, 堤 翼, 田中俊光, 福永秀平, 中野 暖, 川口真知子, 戸次鎮宗, 天野恵介, 中野聖士, 川口 巧. MASLD/MetALDの臨床像. 肝胆膵. 2025. 90. 3. 281-287
  • 堤 翼、鈴木浩之、福永秀平、中野聖士、中野 暖、川口 巧. 特集 脂肪肝の新概念:MASLD 1.日本人MASLDのNatural History. 臨牀消化器内科. 2024. 39. 7. 736-741
  • 堤 翼. 5 . 代謝異常関連脂肪肝は非アルコール性脂肪肝よりも動脈硬化性心血管リスクの悪化を同定する:一般化推定方程式によるアプローチ. 久留米醫學會雜誌. 2023. 86. 11.12. 253
  • 堤 翼、天野恵介、川口 巧. 脂肪肝の新疾患概念「MAFLD」とは. 診断と治療. 2023. 111. 12. 1633-1637
  • 堤 翼、中野 暖、佐野有哉、天野恵介、川口 巧. 特集 全身病としての脂肪性肝疾患 III.予後 脂肪性肝疾患と慢性閉塞性肺疾患. 肝胆膵. 2023. 87. 6. 701-706
more...
Books (3):
  • 新定義MAFLDとNAFLDの違い-脂肪肝の診療は何が変わるか-
    Progress in Medicine、ライフ・サイエンス 2023
  • 2.肝疾患 肝疾患に伴うサルコペニア
    最新ガイドラインに基づく 消化器疾患 診療指針 2023-’24、総合医学社 2023
  • 非がん疾患のエンドオブライフ・ケア(EOLC)に関するガイドライン
    非がん疾患のエンドオブライフ・ケア(EOLC)に関するガイドライン 2021
Lectures and oral presentations  (29):
  • Degree of adherence to the Mediterranean diet is highly predictive of prognosis in patients with MASLD: Findings from NHANES 2011-2018
    (EASL SLD Summit 2025 2025)
  • High adherence to the Mediterranean diet is associated with lower Liver Risk Scores ? Analysis of the NHANES 2017-2018 Cohort
    (The Liver Meeting 2024 (The 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)) 2024)
  • 肝小葉内炎症は肝線維化よりもMASLDの予後に関わる:全国多施設共同研究
    (第60回日本肝臓学会総会 2024)
  • Hepatic Lobular Inflammation is the Most Impacted Prognostic Factor in MAFLD: A Multi-Center Study
    (APASL 2024 Kyoto-The Center of Hepatology 2024)
  • MAFLDの慢性閉塞性肺疾患(COPD)の併発に関する代謝異常の意義
    (第45回日本肝臓学会西部会 2023)
more...
Professional career (1):
  • M.D., Ph.D.
Awards (9):
  • 2025/01 - EASL SLD Summit 2025 EASL Young Investigator Bursary Degree of adherence to the Mediterranean diet is highly predictive of prognosis in patients with MASLD: Findings from NHANES 2011-2018
  • 2024/06 - 第60回日本肝臓学会総会 日本肝臓学会 Hepatology Reserch High Citation Award MAFLD Better Predicts the Progression of Atherosclerotic Cardiovascular Risk than NAFLD: Generalized Estimating Equation Approach
  • 2024/03 - APASL 2024 Kyoto AASLD - APASL Early Career Investigator Award Hepatic Lobular Inflammation is the Upstream Prognostic Factor in Patients with Biopsy-Proven MAFLD: A Multi-Center Study
  • 2023/11 - AASLD2023 The Professor Mindie H. Nguyen Award for Outstanding Clinical Research by Early Career Investigators Hepatic Lobular Inflammation is The Most Impacted Prognostic Factor Rather than Fibrosis in Patients with Biopsy-proven MASLD: Multi-Center study
  • 2023 - 久留米大学 令和5年度久留米大学学術奨励賞 MAFLD Better Predicts the Progression of Atherosclerotic Cardiovascular Risk than NAFLD: Generalized Estimating Equation Approach
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page